Lexaria Bioscience Corp
For the period ended Nov 30, 2024. Filed Jan 10, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Nov 30, 2024 · Filed Jan 10, 2025
LEXX$4.68+3.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. 10b5-1 Trading Plans
Item 2. Recent Sales of Unregistered Equity Securities
During the quarter ended November 30, 2024 the Company did not issue any unregistered equity securities.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.